Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now full pipeline small index

Opioid Analgesia: full-pipeline trial registry

1 of 2 indexed Opioid Analgesia trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Opioid Analgesia: 2 US clinical trials tracked, 1 recruiting.

Opioid Analgesia is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Purdue Pharma, running 1 of these trials.

Enrollment posture brief

Registry condition opioid-analgesia

OPEN 1 | RECR 50% | LATE 1 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Opioid Analgesia (this)50%
Open-enrollment share among volume-matched conditions near Opioid Analgesia

Opioid Analgesia lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Opioid Analgesia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Opioid Analgesia is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 1

Top Sponsors

Purdue Pharma 1 trials

Named interventions

Most-linked intervention names on Opioid Analgesia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Oxycodone hydrochloride controlled-release (ORF) tablets Drug
1 trials
Buprenorphine Transdermal System Drug
1 trials
Placebo Patch Drug
1 trials

US sites by state

Facility locations filed on Opioid Analgesia trials. A trial with sites in several states counts in each.

Wisconsin 1 trials
Washington 1 trials
Texas 1 trials
Pennsylvania 1 trials
Oklahoma 1 trials
Ohio 1 trials
Missouri 1 trials
Michigan 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Opioid Analgesia page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Opioid Analgesia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Purdue Pharma sponsors the most Opioid Analgesia trials on record, review their full trial history before evaluating a specific study. See Purdue Pharma's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Opioid Analgesia condition card totals 2 registered trials; most-linked intervention Oxycodone hydrochloride controlled-release (ORF) tablets; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.